Emilia Grycuk

Emilia Grycuk

Auto-generated profile, based on publicly available information

Emilia Grycuk

School of Medicine Trinity College Dublin Dublin Ireland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Open access
EGEmilia Grycuk
Emilia Grycuk
Yaohua Sophie ChenYaohua Sophie Chen
Yaohua Sophie Chen
AAArianna Almirall‐Sanchez
Arianna Almirall‐Sanchez
DHDawn Higgins
Dawn Higgins
MGMiriam Galvin
Miriam Galvin
ILIracema College Leroi
Iracema College Leroi
Background: Public health restrictions due to the COVID‐19 (SARS CoV‐2) pandemic have disproportionately affected informal caregivers of people living with long term health conditions. We aimed to explore levels of care burden, loneliness, and social isolation among caregivers of people with enduring physical and brain health conditions in English‐speaking regions worldwide, by investigating outcomes before and during the COVID‐19 pandemic.Methods: A cross‐sectional anonymous online survey data from 2287 English‐speaking caregivers of people with long term health conditions from four English‐speaking regions (UK, Ireland, USA, New Zealand) included measures of care burden, loneliness, and social isolation, reported before and during the COVID‐19 pandemic. Analyses were descriptive, followed by an ordinal regression model for predictors of burden.Results: Compared to pre‐pandemic levels, all caregivers experienced a significant increase in burden, loneliness, and isolation. Caregivers of people with both brain health and physical conditions were the most burdened and had the highest levels of loneliness and isolation compared to caregivers of people with either a brain health or physical condition only. The increase in care burden among caregivers of people with brain health challenges was associated with caregiver's gender, moderate and severe emotional loneliness, magnitude and frequency of isolation during the pandemic, and care circumstances (cohabitation with the care recipient, restrictions on the ability to provide care).Conclusions: Health and social care interventions should target caregivers' care circumstances and psychological outcomes, particularly in women, accounting for the significant additional burden of care, loneliness, and isolation resulting from pandemic‐related restrictions.

11 July 2025 in Alzheimer's & Dementia: Translational Research & Clinical Interventions
Verified
Journal Article
Open access
JKJoseph P. M. Kane
Joseph P. M. Kane
RFRachel L. Fitzpatrick
Rachel L. Fitzpatrick
SBSara Betzhold
Sara Betzhold
GDGillian Daly
Gillian Daly
EKEmily Kalfas
Emily Kalfas
ILIracema College Leroi
Iracema College Leroi
INTRODUCTION: Methodological heterogeneity in dementia with Lewy bodies (DLB) trials contributes to publication bias and makes evidence synthesis and meta‐analysis challenging. We aimed to develop a core outcome set for DLB (DLB COS) trials to improve consistency and comparability in DLB research. METHODS: We conducted a systematic review to identify outcomes and administered a two‐stage Delphi survey to a diverse panel of lay and professional stakeholders. We asked respondents which outcomes should be prioritized and included in DLB COS. RESULTS: Forty‐nine outcomes were presented to survey respondents. Consensus was reached regarding eight outcomes for the final DLB COS: delusions/paranoia; fluctuations in cognition, attention, and arousal; functioning; global cognition; hallucinations; quality of life; motor parkinsonism; and rapid eye movement sleep behavior disorder. DISCUSSION: If adopted, DLB COS can enhance the comparability of research findings and facilitate standardization and harmonization. Highlights: A systematic review revealed heterogeneity in dementia with Lewy bodies (DLB) study outcomes. Our study produced a DLB Core Outcome Set (DLB COS) comprising eight outcomes. DLB COS sets the minimum reporting standards for future trials. DLB‐specific rating scales incorporating these outcomes are needed. Addressing this gap is a strategic priority in DLB research.